Patient attributes rather than treatment factors are a better predictor of outcome.
There is a poor prognosis with:
•
Established brain damage.•
Co-morbid psychiatric illness, especially antisocial personality disorder.•
Criminal history.•
Low IQ.•
Poor support.•
Low motivation.Follow-up
•
Sixty per cent with ‘good’ outcome at 20.8 months; 40 per cent in remission and 19 per cent with no more than three relapses and continuous sobriety 6 months prior to survey (Castle Craig Hospital Extended Care Unit Follow-up Study, 1999).•
Self-reports for follow-up study are about 90 per cent reliable (Secades-Villa and Fernandez-Hermida, 2003).120 ALCOHOL DEPENDENCE
REFERENCES AND FURTHER READING
Anderson P, Cremona A, Paton A et al. (1993) The risk of alcohol. Addiction 8, 1493.
Babor TF, Hofmann M, DelBoca JK et al. (1992) Types of alcoholics. I: Evidence for an empiric-ally derived typology based on indicators of vulnerability and severity. Arch. Gen. Psychiatry 49, 599.
Bolnick JM, Rayburn WF (2003) Substance use disorders in women: special considerations dur-ing pregnancy. Obstet. Gynecol. Clin. North Am. 30, 545.
Brook DW, Brook JS, Zhang C et al. (2002) Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch. Gen. Psychiatry 59, 1039.
Brun A, Andersson J (2001) Frontal dysfunction and frontal cortical synapse loss in alcoholism:
the main cause of alcohol dementia? Dement. Geriatr. Cogn. Disord. 12, 289.
Castle Craig Hospital (1999) Castle Craig Hospital Extended Care Unit Follow-up Study 1999.
www.castlecraig.co.uk/treatment/ecu_followup_1999p.htm (accessed 1 January 2004).
Chasnoff IJ (1991) Drugs, alcohol, pregnancy, and the neonate: pay now or later. JAMA 266, 1567.
Chick J (1993) Benno Pollack Lecture, (1992) Alcohol dependence: an illness with a treatment?
Addiction 8, 1481.
Ciraulo DA, Piechniczek-Buczek J, En I (2003) Outcome predictors in substance use disorders.
Psychiatr. Clin. North Am. 26, 381.
Cloninger CR (1987) Neurogenic adaptive mechanisms in alcoholism. Science 23, 410.
Collins GB (1993) Contemporary issues in the treatment of alcohol dependence. Psychiatr. Clin.
North Am. 16, 33.
Condren RM, O’Connor J, Browne R (2001) Prevalence and patterns of substance misuse in schizophrenia: a catchment area case–control study. Psychiatr. Bull. 25, 17.
Curran GM (2003) Emergency department use of persons with comorbid psychiatric and sub-stance abuse disorders. Ann. Emerg. Med. 41, 659.
Edwards G, Gross MM (1976) Alcohol dependence: provisional description of a clinical syn-drome. BMJ 1, 1058.
Enoch MA, Goldman D (2002) Problem drinking and alcoholism: diagnosis and treatment. Am.
Fam. Physician 65, 441.
Faculty of Public Health Medicine (1991) Alcohol and the Public Health. Macmillan, London.
Fleming MF, Mundt MP, French MT et al. (2002) Brief physician advice for problem drinkers:
long-term efficacy and benefit–cost analysis. Alcohol Clin. Exp. Res. 26, 36.
Gelernter J, Goldman D, Risch N (1993) The Al allele at the D2dopamine receptor gene and alco-holism. JAMA 269, 1673.
Greenfield S, Manwani SG, Nargiso JE (2003) Epidemiology of substance use disorders in women. Obstet. Gynecol. Clin. North Am. 30, 413.
Hearne R, Connolly A, Sheehan J (2002) Alcohol abuse: prevalence and detection in a general hospital. J. Royal Soc. Med. 95, 84.
Heath DB (2001) Culture and substance abuse. Psychiatr. Clin. North Am. 24, 479.
Heilig M, Thorsell A (2002) Brain neuropeptide Y (NPY) in stress and alcohol dependence. Rev.
Neurosci. 13, 85.
Helzer JE, Pryzbeck TR (1991) The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J. Stud. Alcohol 49, 219.
Hopfer CJ, Crowley TJ, Hewitt JK (2003) Review of twin and adoption studies of adolescent sub-stance use. J. Am. Acad. Child Adolesc. Psychiatry 42, 710.
Iacono WG, Carlson SR, Malone SM, McGue M (2002) P3 event-related potential amplitude and the risk for disinhibiroty disorders in adolescent boys. Arch. Gen. Psychiatry 59, 750.
Ilveskoski E, Kajander OA, Lehtimäki T et al. (2001) Association of neuropeptide Y polymorph-ism with the occurrence of type 1 and type 2 alcoholpolymorph-ism. Alcohol Clin. Exp. Res. 10, 1420.
REFERENCES AND FURTHER READING 121
Jackson KM, Sher KJ, Wood PK, Bucholz KK (2003) Alcohol and tobacco use disorders in a gen-eral population: short-term and long-term associations from the St Louis Epidemiological Catchment Area Study. Drug Alcohol Depend. 71, 239.
Johnson BA, Roache JD, Ait-Daoud N et al. (2002) Ondansetron reduces the creving of biologic-ally predisposed alcoholics. Psychopharmacology 160, 408.
Kendler KS, Heath AC, Neale MC et al. (1992) A population-based twin study of alcoholism in women. JAMA 268, 1877.
Kiefer F, Jahn H, Tarnaske T (2003) Comparing and combing naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch. Gen.
Psychiatry 60, 92.
Koren G, Nulman I, Chudley AE, Loocke C (2003) Fetal alcohol spectrum disorder. CMAJ 169, 1181.
Lingford-Hughes A, Nutt D (2002) Neurobiology of addiction and implications for treatment.
Br. J. Psychiatry 182, 97.
Litt MD, Babor TF, DelBoca FK et al. (1992) Types of alcoholics. II: Application of an empirically derived typology to treatment matching. Arch. Gen. Psychiatry 49, 609.
Madden JS (1993) Depression: alcohol and depression. Br. J. Hosp. Med. 50(5), 265.
Markianos M, Lykouras L, Moussas G et al. (2001) Changes in dopamine receptor responsivity during alcohol detoxification may predict relapse. Drug Alcohol Depend. 64, 363.
Martin SE (2001) The links between alcohol, crime and the criminal justice system: explanations, evidence and interventions. Am. J. Addict. 10, 136.
Mayfield RD, Lewohl JM, Dodd PR et al. (2002) Patterns of gene expression are altered in the frontal and motor cortices of human alcoholics. J. Neurochem. 81, 802.
McGovern MP, Carroll KM (2003) Evidence-based practices for substance use disorders.
Psychiatr. Clin. North Am. 26, 991.
Meszaros K, Lenzinger E, Hornik K et al. (1999) The tridimensional personality questionnaire as a predictor of relapse in detoxified alcohol dependents. The European Fluvoxamine in Alcoholism Study Group. Alcohol. Clin. Exp. Res. 23, 483.
Monterosso JR, Flannery BA, Pettinati HM et al. (2001) Predicting treatment response in nal-trexone: the influence of craving and family history. Am. J. Addict. 10, 258.
National Institute on Alcohol Abuse and Alcoholism (2000) NIH publication no. 00-1583.
National Survey on Drug Use and Health, Substance Abuse and Mental Health Services Adminis-tration (SAMHSA) (2002). www.samhsa.gov/oas/nhsda/2k2nsduh/Results/2k2Results.htm.
Overman GP, Teter CJ, Guthrie SK (2003) Acamprosate for the adjunctive treatment of alcohol dependence. Ann. Pharmacother. 37, 1090.
Pandey SC, Carr LG, Heilig M et al. (2003) Neuropeptide y and alcoholism: genetic, molecular, and pharmacological evidence. Alcohol. Clin. Exp. Res. 27, 149.
Pettinati HM, Volpicelli JR, Pierce JD et al. (2000) Improving naltrexone response: an interven-tion for medical practicioners to enhance medicainterven-tion compliance in alcohol dependent patients. J. Addict. Dis. 19, 71.
Pickens RW, Svikis DS, McGue M et al. (1991) Heterogeneity in the inheritance of alcoholism: a study of male and female twins. Arch. Gen. Psychiatry 48, 19.
Rice DP, Kelman S, Miller LS (1991) Estimates of economic costs of alcohol and drug abuse and mental illness, 1985 and 1988. Public Health Rep. 106, 280.
Sattar SP, Petty F, Burke WJ (2003) Diagnosis and treatment of alcohol dependence in older alco-holics. Clin. Geriatr. Med. 19, 743.
Secades-Villa R, Fernandez-Hermida JR (2003) The validity of self-reports in a follow-up study with drug addicts. Addict. Behav. 28, 1175.
Shivani R, Goldsmith RJ, Anthenelli RM (2002) Alcoholism and psychiatric disorders: diagnostic challenges. Alcohol Res. Health 26, 90.
Sullivan JT, Sykora K, Schneiderman J et al. (1989) Assessment of alchol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br. J. Addict. 84, 1353.
122 ALCOHOL DEPENDENCE